Association between Gut Microbiota Compositions with Microvascular Complications in Individuals with Diabetes: A Systematic Review

  • Authors: Hasani M.1, Asadi Pilerud Z.2,3, Kami A.4, Abbas Vaezi A.5, Sobhani S.6, Ejtahed H.7,8, Qorbani M.6,9
  • Affiliations:
    1. Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
    2. Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran
    3. Golestan University of Medical Sciences, Gorgan, Iran
    4. Department of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
    5. Noncommunicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
    6. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
    7. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
    8. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Issue: Vol 20, No 10 (2024)
  • Section: Medicine
  • URL: https://snv63.ru/1573-3998/article/view/642958
  • DOI: https://doi.org/10.2174/0115733998280396231212114345
  • ID: 642958

Cite item

Full Text

Abstract

Background::Diabetes is one of the chronic and very complex diseases that can lead to microvascular complications. Recent evidence demonstrates that dysbiosis of the microbiota composition might result in low-grade, local, and systemic inflammation, which contributes directly to the development of diabetes mellitus and its microvascular consequences.

Objective::The aim of this systematic review was to investigate the association between diabetes microvascular complications, including retinopathy, neuropathy, nephropathy, and gut microbiota composition.

Methods::A systematic search was carried out in PubMed, Scopus, and ISI Web of Science from database inception to March 2023. Screening, data extraction, and quality assessment were performed by two independent authors. The Newcastle-Ottawa Quality Assessment Scale was used for quality assessment.

Results::About 19 articles were selected from 590 retrieved articles. Among the included studies, nephropathy has been studied more than other complications of diabetes, showing that the composition of the healthy microbiota is changed, and large quantities of uremic solutes that cause kidney injury are produced by gut microbes. Phyla, including Fusobacteria and Proteobacteria, accounted for the majority of the variation in gut microbiota between Type 2 diabetic patients with and without neuropathy. In cases with retinopathy, an increase in pathogenic and proinflammatory bacteria was observed.

Conclusion::Conclusion: Our results revealed that increases in Bacteroidetes, Proteobacteria and Fusobacteria may be associated with the pathogenesis of diabetic nephropathy, neuropathy, and retinopathy.

:In view of the detrimental role of intestinal dysbiosis in the development of diabetes-related complications, gut microbiota assessment may be used as a biomarker in the future and interventions that modulate the composition of microbiota in individuals with diabetes can be used to prevent and control these complications.

About the authors

Motahareh Hasani

Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran

Author for correspondence.
Email: info@benthamscience.net

Zahra Asadi Pilerud

Student Research
Committee, Alborz University of Medical Sciences, Karaj, Iran;

Email: info@benthamscience.net

Atefe Kami

Golestan University of Medical Sciences, Gorgan,
Iran

Email: info@benthamscience.net

Amir Abbas Vaezi

Department of Internal Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Author for correspondence.
Email: info@benthamscience.net

Sahar Sobhani

Noncommunicable
Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran

Email: info@benthamscience.net

Hanieh-Sadat Ejtahed

Obesity and Eating Habits
Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences,
Tehran, Iran; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute,
Tehran University of Medical Sciences, Tehran, Iran

Email: info@benthamscience.net

Mostafa Qorbani

Noncommunicable
Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Chronic Diseases Research Center, Endocrinology and Metabolism
Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Email: info@benthamscience.net

Supplementary files

Supplementary Files
Action
1. JATS XML